Aptima molecular diagnostic assays
GPTKB entity
Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
molecular diagnostic assay
|
| gptkbp:detects |
gptkb:COVID-19
gptkb:Chlamydia_trachomatis gptkb:Mycoplasma_genitalium gptkb:Trichomonas_vaginalis gptkb:HIV-1 gptkb:Neisseria_gonorrhoeae gptkb:Human_papillomavirus_(HPV) gptkb:Hepatitis_B_virus_(HBV) gptkb:Hepatitis_C_virus_(HCV) |
| gptkbp:developedBy |
gptkb:Hologic,_Inc.
|
| gptkbp:feature |
high sensitivity
high specificity automation compatible |
| https://www.w3.org/2000/01/rdf-schema#label |
Aptima molecular diagnostic assays
|
| gptkbp:marketedAs |
early 2000s
|
| gptkbp:platform |
gptkb:Panther_system
gptkb:Tigris_system |
| gptkbp:regulates |
gptkb:FDA
gptkb:CE_Mark |
| gptkbp:technology |
gptkb:Transcription-Mediated_Amplification_(TMA)
|
| gptkbp:type |
gptkb:plasma
blood urine swab |
| gptkbp:usedFor |
infectious disease detection
|
| gptkbp:bfsParent |
gptkb:HOLX
|
| gptkbp:bfsLayer |
7
|